Neurokinin 3 Receptor Antagonist [EPC]

2301 reported adverse events

Drugs of this class: FEZOLINETANT

These side effects are most commonly reported by patients taking drugs of the Neurokinin 3 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 281
1 HEPATIC ENZYME INCREASED 217
2 ALANINE AMINOTRANSFERASE INCREASED 200
3 ASPARTATE AMINOTRANSFERASE INCREASED 153
4 HEADACHE 130
5 OFF LABEL USE 124
6 NAUSEA 110
7 HOT FLUSH 107
8 LIVER FUNCTION TEST INCREASED 98
9 INSOMNIA 94
See all common reactions for Neurokinin 3 Receptor Antagonist [EPC]

Drugs of the Neurokinin 3 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIVER FUNCTION TEST INCREASED 98 0.0046
1 MENOPAUSAL SYMPTOMS 10 0.0043
2 ALANINE AMINOTRANSFERASE INCREASED 200 0.0033
3 HEPATIC ENZYME INCREASED 217 0.0032
4 ASPARTATE AMINOTRANSFERASE INCREASED 153 0.0029
5 LOSS OF THERAPEUTIC RESPONSE 8 0.0025
6 GAMMA-GLUTAMYLTRANSFERASE INCREASED 43 0.0019
7 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
8 HEPATIC PAIN 8 0.0019
9 HEPATIC ENZYME ABNORMAL 9 0.0018
See all enriched reactions for Neurokinin 3 Receptor Antagonist [EPC]